Ignite Creation Date:
2025-12-24 @ 2:16 PM
Ignite Modification Date:
2026-01-29 @ 8:12 AM
Study NCT ID:
NCT01435395
Status:
COMPLETED
Last Update Posted:
2016-04-27
First Post:
2011-09-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Trial of Temozolomide, Bevacizumab Plus Bortezomib for Recurrent Glioblastoma Multiforme
Sponsor:
Emory University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
IRB00014595
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None